Celldex Therapeutics | CLDX - Beban Penjualan Dan Administrasi





Beban Penjualan Dan Administrasi Perubahan Tanggal
AbbVie USD 3.63B 54M 2026-06
Agenus USD 6.21M 4.34M 2026-03
Amgen USD 1.72B 134M 2026-06
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Celldex Therapeutics USD 13.1M 1.65M 2026-06
Glaxosmithkline GBP 2.12B 1.44B 2026-03
Nektar Therapeutics USD 11.87M 1.7M 2026-03
Northwest Biotherapeutics USD 6.54M 534K 2026-03
Pfizer USD 3.41B 496M 2026-06
Rigel Pharmaceuticals USD 27.04M 1M 2024-09
Roche Holding CHF 6.37B 908M 2026-06